These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 24180402)

  • 1. Strategy for the treatment of Helicobacter pylori infection.
    Shiota S; Yamaoka Y
    Curr Pharm Des; 2014; 20(28):4489-500. PubMed ID: 24180402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Helicobacter pylori-associated diseases].
    Gisbert JP
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():39-48. PubMed ID: 26520195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of Helicobacter pylori infection: which regimen first?
    Federico A; Gravina AG; Miranda A; Loguercio C; Romano M
    World J Gastroenterol; 2014 Jan; 20(3):665-72. PubMed ID: 24574740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel and Effective Therapeutic Regimens for
    Hu Y; Zhu Y; Lu NH
    Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary antibiotic resistance of Helicobacter pylori strains and eradication rate according to gastroduodenal disease in Korea].
    Kim JY; Kim N; Park HK; Jo HJ; Shin CM; Lee SH; Park YS; Hwang JH; Kim JW; Jeong SH; Lee DH; Nam RH; Kim JM; Lee JH; Jung HC; Song IS
    Korean J Gastroenterol; 2011 Dec; 58(2):74-81. PubMed ID: 21873821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection.
    Fock KM; Katelaris P; Sugano K; Ang TL; Hunt R; Talley NJ; Lam SK; Xiao SD; Tan HJ; Wu CY; Jung HC; Hoang BH; Kachintorn U; Goh KL; Chiba T; Rani AA;
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1587-600. PubMed ID: 19788600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Helicobacter pylori infection.
    Costa F; D'Elios MM
    Expert Rev Anti Infect Ther; 2010 Aug; 8(8):887-92. PubMed ID: 20695744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-line rescue treatment of
    Lin TF; Hsu PI
    World J Gastroenterol; 2018 Oct; 24(40):4548-4553. PubMed ID: 30386104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric MALT lymphoma and Helicobacter pylori.
    Salar A
    Med Clin (Barc); 2019 Jan; 152(2):65-71. PubMed ID: 30424932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori.
    Malfertheiner P; Selgrad M
    Curr Opin Gastroenterol; 2014 Nov; 30(6):589-95. PubMed ID: 25268839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Watanabe K; Fujioka T
    J Clin Gastroenterol; 2008 Feb; 42(2):139-42. PubMed ID: 18209581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.
    Kato S; Shimizu T; Toyoda S; Gold BD; Ida S; Ishige T; Fujimura S; Kamiya S; Konno M; Kuwabara K; Ushijima K; Yoshimura N; Nakayama Y;
    Pediatr Int; 2020 Dec; 62(12):1315-1331. PubMed ID: 32657507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.
    Fallone CA; Moss SF; Malfertheiner P
    Gastroenterology; 2019 Jul; 157(1):44-53. PubMed ID: 30998990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy.
    Tarhini M; Fayyad-Kazan M; Fayyad-Kazan H; Mokbel M; Nasreddine M; Badran B; Kchour G
    Microb Pathog; 2018 Apr; 117():23-26. PubMed ID: 29428426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Helicobacter pylori eradication therapy in Korea].
    Kim SY; Jung SW
    Korean J Gastroenterol; 2011 Dec; 58(2):67-73. PubMed ID: 21873820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori infection in Singapore? Results of a time trend analysis.
    Ang TL; Wang L; Ang D; Chiam P; Fock KM; Teo EK
    J Dig Dis; 2013 Feb; 14(2):100-4. PubMed ID: 23253473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neither 10- nor 14-Day Sequential Treatment is better than Standard Triple Therapy for Helicobacter Pylori Eradication.
    Warrington E; López-Román O; Tirado Montijo R; Urbina R; Cruz-Correa M; Toro DH
    P R Health Sci J; 2016 Dec; 35(4):203-208. PubMed ID: 27898166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: a systematic review.
    Nagaraja V; Eslick GD
    World J Gastroenterol; 2014 Oct; 20(40):14527-36. PubMed ID: 25356018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.